A single-dose gene therapy has demonstrated remarkable results in slowing the advancement of Huntington’s disease during a preliminary trial, according to a press release from University College London (UCL). Researchers…
AMT-130
-
-
The Long-Awaited Three-Year Study Results on Huntington’s Disease AMT-130, uniQure’s gene therapy, would be the first genetic treatment for Huntington’s disease, if approved. The observed slowing of disease progression is…